coin assets, See results about

Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.Joint Statement by the Foreign Ministers of People's Republic of China (PRC) and the Arab Republic of Egypt (full text) and Joint Statement by the Foreign Ministers of People's Republic of China (PRC) and the Arab Republic of Egypt 1. On December 13, 2024, Commissioner the Political Bureau of the Communist Party of China (CPC) Central Committee and Foreign Minister Wang Yi held a strategic dialogue with Egyptian Minister of Foreign Affairs and Immigration Abdul Atti. 2. The two sides exchanged in-depth and comprehensive views on China-Egypt relations and international and regional issues of common concern, and jointly reviewed the development achievements made by the two countries since the establishment of diplomatic relations, especially since the establishment of a comprehensive strategic partnership 10 years ago. 3. The two sides stressed the need to implement the important consensus reached by the two heads of state at their two meetings in 2024, take the "China-Egypt Year of Partnership" as a new starting point, and push bilateral relations to a higher goal of building a community of destiny between China and Egypt facing the new era. The two sides appreciated the many diplomatic, economic, trade, investment, cultural and tourism activities held by the two countries this year to promote and develop bilateral relations in various fields. (Xinhua News Agency)Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.

State Financial Supervision and Administration: Actively guide banks and insurance institutions to reduce costs and increase efficiency, and broaden capital replenishment channels. On December 13, the Party Committee of the State Financial Supervision and Administration held a meeting to convey the spirit of studying the Central Economic Work Conference, and to study and deploy implementation measures in light of the requirements of the National Financial System Work Conference. The meeting called for promoting the high-quality development of the banking and insurance industry, actively guiding banking and insurance institutions to reduce costs and increase efficiency, broadening capital replenishment channels, and improving sustainable development capabilities. Promote high-level financial openness with higher standards and greater efforts, and attract more foreign financial institutions and long-term capital to set up businesses in China.Senior EU officials: The foreign ministers of 27 EU countries will approve the 15th round of sanctions against Russia and new sanctions "against hybrid operations" on December 16th.Liu Jianchao met with Egyptian Foreign Minister Abdul Ati. On December 13th, Liu Jianchao, Minister of the International Liaison Department of the CPC Central Committee, met with Egyptian Foreign Minister Abdul Ati in Beijing. The two sides exchanged views on implementing the important consensus of the two heads of state, strengthening inter-party exchanges, strengthening political dialogue and humanities exchanges, and promoting the construction of a community of destiny between China and Egypt facing the new era. (Xinhua News Agency)

Yunnan Nengtou: It is planned to invest in Yongning wind farm expansion project. Yunnan Nengtou announced that Maitreya Company, a wholly-owned subsidiary, plans to invest in Yongning wind farm expansion project (Maitreya area), with a total installed capacity of 230,000 kilowatts and a total investment of 1.323 billion yuan (including 6.9 million yuan in working capital). On the same day, it was announced that Honghe Company, a wholly-owned subsidiary, planned to invest in the Yongning Wind Farm Expansion Project (Luxi Area), with a total installed capacity of 235,000 kilowatts and a total investment of 1.395 billion yuan (including 7.05 million yuan in working capital).Domestic futures opened mixed at night, with Shanghai Gold down 0.57%, Shanghai Silver down more than 1%, Shanghai Zinc up 0.68%, thread down 0.5%, coking coal down 0.6%, glass down 1.22% and crude oil up nearly 1%.BYD Lian Yubo: It is estimated that BYD will sell 4.25 million vehicles in the whole year. On December 13th, BYD's chief scientist Lian Yubo said: "Up to now, BYD has sold more than 10 million new energy vehicles. By the end of this month, we can probably achieve the annual sales of 4.25 million vehicles. " He also mentioned: "There are still some challenges in industrial development. For example, the overall anti-risk ability of our industrial chain needs to be improved, and there are still breakthroughs in chips, operating technologies, industrial software and nuclear materials. We still need to strengthen research and achieve complete autonomy and controllability."